Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$121.32M+33.8%$115.13M+28.9%$105.82M+23.4%$89.85M+8.3%$90.66M+6.7%
$8.82M+44.0%$7.85M+15.0%$7.6M+40.3%$6.31M+31.2%$6.13M+25.8%
$87.28M+57.0%$78.03M+39.3%$69.79M+28.8%$57.56M+5.0%$55.61M+7.4%
$15.81M+5.4%$15.04M+4.9%$14.26M-6.4%$13.77M-7.9%$15M+1.0%
$56.09M+59.5%——————$35.17M—
$732K———————$0—
$55.67M+50.5%$40.1M+17.4%$38.16M-11.7%$32.86M+15.1%$36.99M+4.9%
45.9%+5.1pp34.8%-3.4pp36.1%-14.4pp36.6%+2.2pp40.8%-0.7pp
$1.15+45.6%$0.82+10.8%$0.80-16.7%$0.69+6.2%$0.79-2.5%
$97.45M+39.0%——————$70.08M—
80.3%+3.0pp——————77.3%—
$71.9M+43.3%——————$50.17M—

FAQ

What is National Health Investors's revenue?
National Health Investors (NHI) generated $432.1M in revenue over the trailing twelve months, up 23.9% year over year.
Is National Health Investors profitable?
National Health Investors reported $166.8M in net income over the trailing twelve months, a 38.6% net margin.
What is National Health Investors's earnings per share?
National Health Investors's diluted EPS over the trailing twelve months is $3.46.
Where does National Health Investors's income statement data come from?
Every line is extracted from National Health Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.